BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31668663)

  • 1. N-WASP Control of LPAR1 Trafficking Establishes Response to Self-Generated LPA Gradients to Promote Pancreatic Cancer Cell Metastasis.
    Juin A; Spence HJ; Martin KJ; McGhee E; Neilson M; Cutiongco MFA; Gadegaard N; Mackay G; Fort L; Lilla S; Kalna G; Thomason P; Koh YWH; Norman JC; Insall RH; Machesky LM
    Dev Cell; 2019 Nov; 51(4):431-445.e7. PubMed ID: 31668663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-WASP Guides Cancer Cells toward LPA.
    Rottner K; Schaks M
    Dev Cell; 2019 Nov; 51(4):415-417. PubMed ID: 31743660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
    Komachi M; Sato K; Tobo M; Mogi C; Yamada T; Ohta H; Tomura H; Kimura T; Im DS; Yanagida K; Ishii S; Takeyoshi I; Okajima F
    Cancer Sci; 2012 Jun; 103(6):1099-104. PubMed ID: 22348348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
    Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
    J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
    Yoshikawa K; Tanabe E; Shibata A; Inoue S; Kitayoshi M; Okimoto S; Fukushima N; Tsujiuchi T
    Exp Cell Res; 2013 Feb; 319(3):105-12. PubMed ID: 23041208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
    Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
    Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells.
    Kim EK; Park JM; Lim S; Choi JW; Kim HS; Seok H; Seo JK; Oh K; Lee DS; Kim KT; Ryu SH; Suh PG
    J Biol Chem; 2011 Jul; 286(27):24036-45. PubMed ID: 21602274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.
    Muinonen-Martin AJ; Susanto O; Zhang Q; Smethurst E; Faller WJ; Veltman DM; Kalna G; Lindsay C; Bennett DC; Sansom OJ; Herd R; Jones R; Machesky LM; Wakelam MJ; Knecht DA; Insall RH
    PLoS Biol; 2014 Oct; 12(10):e1001966. PubMed ID: 25313567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
    Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
    J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
    Gardner JA; Ha JH; Jayaraman M; Dhanasekaran DN
    Pancreas; 2013 Jul; 42(5):819-28. PubMed ID: 23508014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis.
    Li J; Li Z; Jiang P; Peng M; Zhang X; Chen K; Liu H; Bi H; Liu X; Li X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):177. PubMed ID: 30064461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
    Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
    PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions.
    Lubeseder-Martellato C; Alexandrow K; Hidalgo-Sastre A; Heid I; Boos SL; Briel T; Schmid RM; Siveke JT
    EBioMedicine; 2017 Feb; 15():90-99. PubMed ID: 28057438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
    Ward Y; Lake R; Yin JJ; Heger CD; Raffeld M; Goldsmith PK; Merino M; Kelly K
    Cancer Res; 2011 Dec; 71(23):7301-11. PubMed ID: 21978933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2.
    Kim HS; Lee YS; Dong SM; Kim HJ; Lee DE; Kang HW; Kim MJ; Park JS
    Oncol Res; 2024; 32(4):615-624. PubMed ID: 38560567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
    Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
    Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
    Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.